Constitutional Mismatch Repair Deficiency Syndrome
3 clinical trials · Condition
◉ Watch Constitutional Mismatch Repair Deficiency Syndrome
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study (NCT04500548) | National Cancer Institute (NCI) | 2021-05-11 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma (NCT02359565) | National Cancer Institute (NCI) | 2015-06-03 |
Track Constitutional Mismatch Repair Deficiency Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.